drugset / Trial / NCT02401945

A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration

NCT02401945

Phase 2 Completed 16 enrolled Santen Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the safety and efficacy of intravitreal (IVT) administration of DE-120 in subjects with treatment-naive active subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).

Timeline

Start
2015-04
Primary completion
2016-06-22
Completion
2016-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Aflibercept Protein / enzyme biologic
Subject DE-120 Unknown Intravitreal